• Ronald Lund has been named chief legal officer of AGA Medical (Minneapolis). Previously, Lund was employed at the Minneapolis law firm of Fredrikson & Byron. AGA makes interventional devices to treat structural heart defects.

• Jeremy Curtis has been named VP of worldwide marketing of ATS Medical (Minneapolis). Curtis most recently was general manager, diagnostic cardiology marketing, for GE Healthcare. ATS makes products and services used in cardiac surgery.

• Dennis Atkins has been named director of sales and marketing for Problem Solving Concepts (dba Prosolve Cardiovascular; Indianapolis, Indiana). Previously Curtis was director of field operations at Bristol-Myers Squibb Medical Imaging. ProSolv is a developer of digital imaging and reporting software for cardiologists,

Spectranetics (Colorado Springs, Colorado) reported that it has named Donald Fletcher as VP of quality assurance and regulatory compliance. Fletcher was previously director of quality assurance at Medtronic vascular products. Spectranetics makes the only excimer laser approved in the U.S., Europe and Japan for use in minimally invasive cardiovascular procedures.

• Chris Waddick has been named president/CEO of Vasogen (Mississauga, Ontario). Waddick formerly held a senior management position with Vasogen. Vasogen is a biotech company developing therapies designed to target the inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders.

• Norma Soleno-DeVaney has been appointed CFO for Vidacare (San Antonio), a manufacturer of intraosseious access technology. Soleno-DeVaney most recently was CFO of DocuSource. Prior to that, she held CFO positions with Trestle, IMRI, and as a partner at KGS Consulting, Soleno-DeVaney is also a partner with Tatum, a national executive services firm. Vidacare says that its initial product line, the EZ-IO System, serves the emergent care industry as the world’s only lithium-battery powered drill and patented needle set for gaining immediate vascular access when conventional IV access is difficult or impossible.